首页 | 本学科首页   官方微博 | 高级检索  
检索        

nNOS PDZ抑制剂的合成及其神经保护作用研究
引用本文:马 玉,丁 屹,蔡鋆鑫,常 磊,朱东亚,厉廷有.nNOS PDZ抑制剂的合成及其神经保护作用研究[J].南京医科大学学报,2014(3):314-322.
作者姓名:马 玉  丁 屹  蔡鋆鑫  常 磊  朱东亚  厉廷有
作者单位:南京医科大学药学院,江苏 南京 211166;南京医科大学药学院,江苏 南京 211166;南京医科大学药学院,江苏 南京 211166;南京医科大学药学院,江苏 南京 211166;南京医科大学药学院,江苏 南京 211166;南京医科大学心血管转化医学协同创新中心,江苏 南京 210029;南京医科大学药学院,江苏 南京 211166;南京医科大学心血管转化医学协同创新中心,江苏 南京 210029
基金项目:南京医科大学心血管转化医学协同创新中心项目
摘    要:目的:合成nNOS PDZ抑制剂并评价其神经保护作用?方法:根据nNOS PDZ结构域配体结合部位多碱性中心的结构特点设计并合成多系列双羧酸及其酯类化合物,用谷氨酸诱导的神经元细胞乳酸脱氢酶释放模型评价化合物的神经保护作用?结果:合成了18个目标化合物,其中N-(2-甲氧羰基乙酰基)-D-缬氨酸甲酯 (1)?N-(2-羧基乙酰基)-D-缬氨酸甲酯(2)?N-(2-甲氧羰基乙酰基)-L-缬氨酸甲酯(7)?N-(2-羧基乙酰基)-L-缬氨酸(9)显示较强的神经保护作用?结论:nNOS PDZ结构域抑制剂具有神经保护作用?

关 键 词:神经保护剂  nNOS  乳酸脱氢酶
收稿时间:2013/10/22 0:00:00

Synthesis and neuroprotective effect of nNOS PDZ structural domain inhibitors
Ma Yu,Ding Yi,Cai Yunxin,Chang Lei,Zhu Dongya and Li Tingyou.Synthesis and neuroprotective effect of nNOS PDZ structural domain inhibitors[J].Acta Universitatis Medicinalis Nanjing,2014(3):314-322.
Authors:Ma Yu  Ding Yi  Cai Yunxin  Chang Lei  Zhu Dongya and Li Tingyou
Institution:School of Pharmacy,NJMU,Nanjing 211166;School of Pharmacy,NJMU,Nanjing 211166;School of Pharmacy,NJMU,Nanjing 211166;School of Pharmacy,NJMU,Nanjing 211166;School of Pharmacy,NJMU,Nanjing 211166;Collaborative Innovation Center for Cardiovascular Disease Translational Medicine,NJMU,Nanjing 210029,China;School of Pharmacy,NJMU,Nanjing 211166;Collaborative Innovation Center for Cardiovascular Disease Translational Medicine,NJMU,Nanjing 210029,China
Abstract:Objective:To synthesize nNOS PDZ structural domain inhibitors and evaluate their neuroprotective effects. Methods:Multiple-series of dicarboxylic acids and their ester compounds were designed and synthesized based on the structure characteristic of multi-basic groups of the nNOS PDZ ligand binding domain. The neuroprotective effects of the compounds were evaluated by glutamate-induced lactate dehydrogenase (LDH) release model of neurons. Results:Eighteen target compounds were synthesized including N-(2-methoxycarbonylacetyl)-D-valine methyl ester(1),N-(2-carboxylacetyl)-D-valine methyl ester(2),N-(2-methoxycarbony-lacetyl)-L-valine methyl ester(7),N-(2-carboxylacetyl)-L-valine(9) showed potent neuroprotective effect. Conclusion:nNOS PDZ structural domain inhibitors are neuroprotective.
Keywords:neuroprotective reagents  nNOS  lactate dehydrogenase
本文献已被 CNKI 等数据库收录!
点击此处可从《南京医科大学学报》浏览原始摘要信息
点击此处可从《南京医科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号